New drug combo offers hope for elderly breast cancer patients avoiding surgery
NCT ID NCT02760030
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This phase II trial tested a combination of hormone therapy drugs (fulvestrant or an aromatase inhibitor) plus palbociclib in 14 elderly patients with hormone-responsive breast cancer who either had inoperable tumors or were too frail for surgery. The goal was to see if this drug-only approach could control the cancer without the need for surgery. The study measured how long patients stayed on treatment without it failing, and also tracked changes in cognitive function and overall well-being.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Fulvestrant or an aromatase inhibitor combined with palbociclib
- What this could lead to
- If successful, this drug combination could offer an effective non-surgical treatment option for elderly breast cancer patients who are too frail for surgery or choose not to have it.
- What could go wrong
- This is a small, early-phase trial with only 14 participants, so results may not apply to all patients. The combination may cause side effects like fatigue or low blood counts, and it is not a cure—patients will need ongoing treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESTROGEN RECEPTOR AND/OR PROGESTERONE RECEPTOR POSITIVE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Case Western University
Cleveland, Ohio, 44106, United States
-
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, 43210, United States
-
St. Elizabeth Healthcare
Edgewood, Kentucky, 41017, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Virtual therapy may ease breast cancer treatment side effects
- A gentle jog might be the key to better sleep for breast cancer survivors
- Ovarian suppression plus tamoxifen: a Long-Term bet against breast cancer recurrence
- Can radiation replace surgery for cancer spread to lymph nodes?
- Chemo-Free hope: new pill combo targets Hard-to-Treat breast cancer
- New drug cocktail aims to outsmart resistant breast cancer